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and Future ProspectsIssues about congenital anomalies are of great importance
in public health. Even excluding early fetal loss, it has been
estimated that as many as 3.5% of all live births had some
level of major abnormality, which are referred to as birth
defects.1 Incidences can vary dramatically according to
geographic region, cultural background, ethnic group, and
the efficiency of detection and reporting systems. If minor
abnormalities are included, the incidence would be close to
5%. Worldwide, birth defects are one of the causes of infant
mortality and add extensively to the public healthcare
burden.1
The cause of birth defects is not necessarily genetic, and
various etiologic mechanisms may be applied: chromosomal
anomalies, polygenic disorders, single-gene disorders,
environmental/teratogenic factors, multifactorial scenarios,
and other, unknown, causes.2 Generally speaking, at least
1% of human births have one or more clinically significant
chromosomal abnormalities. Before birth, the effect of
natural selection removes the vast majority of genetically
abnormal embryos. At conception, aneuploidy may affect
any chromosome, but only trisomies of sex chromosomes or
of autosomes for chromosomes 13, 18, or 21, or monosomy
of the X chromosome is compatible for carriers to survive to
the end of pregnancy.2
In terms of incidence, clear chromosome-specific varia-
tions exist, in which larger autosomes (chromosomes 1e12)
are under-represented; as chromosome 16 stands out as
most frequent, followed by chromosomes 22, 21 and 15. Sex
chromosome trisomies are not normally seen in sponta-
neous abortions, for reasons which are not fully-known.3 In
comparison to X chromosome trisomy, which has a survival
rate of 94%, cases with 47, XXY have 100% survival.3 Tri-
somies of chromosomes 13, 18 and 21 are among the few
surviving to birth with uncertain chances. At birth, trisomy
21, leading to Down’s syndrome, has an incidence of 1.3 per
1000, trisomy 18 and trisomy 13 (Patau syndrome) have
incidences of 0.05 per 1000 (Edward syndrome) and 0.1 per
1000, respectively.3
Structural anomalies of chromosomes, including chro-
mosome breakage and abnormal reunion, also occur
frequently in humans. Either they occur following reciprocal1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2013.02.002translocations (the exchange of segments between non-
homologous chromosomes), or two or more breaks within a
chromosome, causing a shift in the position or reversal of
sequence (inversions) at the freed segment of chromatin.
This is particularly the casewith Robertsonian translocation,
involving chromosomes 13e15 and 21e22, so-called “acro-
centrics”, in which the centromere is close to the end of the
chromosomewith a net outcomeof reduction in chromosome
number by one without a phenotypic effect.3 Reciprocal
translocations occur in 1 in 500 people and Robertsonian
translocations in approximately 1 per 1000, mostly affecting
chromosomes 13 and 14, or 14 and 21.3 Chromosomal in-
versions are relatively rare without an exact reported inci-
dence, as many cases are not detected.
As to well-characterized risk factors for chromosomal
abnormalities, the most critical one is older maternal age.
Among recognizable pregnancies, trisomy is at greatest risk
for older mothers, with age-specific rates of 0.07%, 0.11%
and 1% for mothers in their 20s, 30s, and 40s or above,
respectively.4 Nonetheless, there are exceptions for trip-
loidy and monosomy X, which normally happen at a younger
age for mothers. When estimates of maternal trisomy were
calculated, the outcome suggested that in women aged 40
or more, the majority of oocytes may be aneuploid.4
Numerical chromosome abnormalities occur at maternal
age-specific rates with special reference to trisomy. 4 The
other well-known risk factor of bearing a chromosomally
abnormal child is that one of the couples carries a gonadal
or germinal mosaic for a trisomic cell line, which happens
during mitosis in premeiotic divisions of the germ cells and
may affect one or several germ cells. In this kind of trisomic
syndrome (translocation, gonadal, or germinal mosaicism),
cases occur independently of maternal age.
Taiwan’s government started setting up programs to pro-
tect and promote maternal health from 1945. Birth registry
reporting by medical practitioners was officially launched by
the Department of Health of Taiwan in 1995, and later
transferred to the Bureau of Health Promotion, Department
of Health, Taiwan in 2001. Its regulations require reporting of
births with a gestational age of  20 weeks, including live
births and miscarriages. However, further studies into theed by Elsevier Taiwan LLC. All rights reserved.
146 Editorialincidence rates of congenital anomalies and their risk factors
are still warranted in Taiwan.5e7
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